<DOC>
	<DOCNO>NCT02302742</DOCNO>
	<brief_summary>PROGECT registry patient Triple Negative breast cancer ( TNBC ) patient identify germline mutation ( mutation BRCA1 BRCA2 gene ) .</brief_summary>
	<brief_title>Triple Negative Breast Cancer Germline Hereditary Breast Ovarian Cancer Mutation Carrier Registry</brief_title>
	<detailed_description>This study do collect cancer-related information patient triple negative breast cancer patient hereditary genetic mutation . This information help u good understand link genetic change cancer outcome patient triple negative breast cancer .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Ovarian Neoplasms</mesh_term>
	<mesh_term>Triple Negative Breast Neoplasms</mesh_term>
	<mesh_term>Hereditary Breast Ovarian Cancer Syndrome</mesh_term>
	<criteria>Inclusion criterion include : Triple Negative Breast Cancer ER/PR &lt; 10 % HER negative per current ASCO/CAP guideline Stages IIV Any age diagnosis Patient must within 5 year diagnosis Eligible regardless genetic test status Genetic testing recommend patient meet NCCN Medicare guideline AND/OR Germline mutation Carriers Patients deleterious uncertain mutation HBOC gene ( BRCA , PTEN , P53 , PALB2 etc ) eligible regardless type/site cancer Healthy patient harbor mutation also eligible There time limit time diagnosis cancer enrollment . Eligible regardless personal history cancer Exclusion Criteria include : Triple Negative Breast Cancer Patient within five year diagnosis Germline mutation Carriers : Patient carry HBOC mutation classify `` polymorphism '' `` favor polymorphism ''</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Triple Negative Breast Cancer</keyword>
	<keyword>TNBC</keyword>
	<keyword>Hereditary Breast Ovarian Cancer</keyword>
	<keyword>HBOC</keyword>
	<keyword>Prospective Registry</keyword>
</DOC>